176 related articles for article (PubMed ID: 27335167)
1. Chamber-specific differences in human cardiac fibroblast proliferation and responsiveness toward simvastatin.
Rizvi F; DeFranco A; Siddiqui R; Negmadjanov U; Emelyanova L; Holmuhamedov A; Ross G; Shi Y; Holmuhamedov E; Kress D; Tajik AJ; Jahangir A
Am J Physiol Cell Physiol; 2016 Aug; 311(2):C330-9. PubMed ID: 27335167
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA.
Porter KE; Turner NA; O'Regan DJ; Balmforth AJ; Ball SG
Cardiovasc Res; 2004 Mar; 61(4):745-55. PubMed ID: 14985071
[TBL] [Abstract][Full Text] [Related]
3. Impact of statins on cellular respiration and de-differentiation of myofibroblasts in human failing hearts.
Emelyanova L; Sra A; Schmuck EG; Raval AN; Downey FX; Jahangir A; Rizvi F; Ross GR
ESC Heart Fail; 2019 Oct; 6(5):1027-1040. PubMed ID: 31520523
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin.
Porter KE; Turner NA; O'Regan DJ; Ball SG
Cardiovasc Res; 2004 Dec; 64(3):507-15. PubMed ID: 15537504
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin reduces TGF-β1-induced SMAD2/3-dependent human ventricular fibroblasts differentiation: Role of protein phosphatase activation.
Rizvi F; Siddiqui R; DeFranco A; Homar P; Emelyanova L; Holmuhamedov E; Ross G; Tajik AJ; Jahangir A
Int J Cardiol; 2018 Nov; 270():228-236. PubMed ID: 30220377
[TBL] [Abstract][Full Text] [Related]
6. Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure.
Shiroshita-Takeshita A; Brundel BJ; Burstein B; Leung TK; Mitamura H; Ogawa S; Nattel S
Cardiovasc Res; 2007 Apr; 74(1):75-84. PubMed ID: 17270161
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis, autophagy and ER stress in mevalonate cascade inhibition-induced cell death of human atrial fibroblasts.
Ghavami S; Yeganeh B; Stelmack GL; Kashani HH; Sharma P; Cunnington R; Rattan S; Bathe K; Klonisch T; Dixon IM; Freed DH; Halayko AJ
Cell Death Dis; 2012 Jun; 3(6):e330. PubMed ID: 22717585
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin inhibits production of interleukin 6 (IL-6) and IL-8 and cell proliferation induced by tumor necrosis factor-alpha in fibroblast-like synoviocytes from patients with rheumatoid arthritis.
Yokota K; Miyazaki T; Hirano M; Akiyama Y; Mimura T
J Rheumatol; 2006 Mar; 33(3):463-71. PubMed ID: 16511915
[TBL] [Abstract][Full Text] [Related]
9. RhoA signaling modulates cyclin D1 expression in human lung fibroblasts; implications for idiopathic pulmonary fibrosis.
Watts KL; Cottrell E; Hoban PR; Spiteri MA
Respir Res; 2006 Jun; 7(1):88. PubMed ID: 16776827
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin inhibits TGFβ1-induced fibronectin in human airway fibroblasts.
Schaafsma D; McNeill KD; Mutawe MM; Ghavami S; Unruh H; Jacques E; Laviolette M; Chakir J; Halayko AJ
Respir Res; 2011 Aug; 12(1):113. PubMed ID: 21864337
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin inhibits cell growth and induces apoptosis and G0/G1 cell cycle arrest in hepatic cancer cells.
Relja B; Meder F; Wilhelm K; Henrich D; Marzi I; Lehnert M
Int J Mol Med; 2010 Nov; 26(5):735-41. PubMed ID: 20878096
[TBL] [Abstract][Full Text] [Related]
12. Screening for YAP Inhibitors Identifies Statins as Modulators of Fibrosis.
Santos DM; Pantano L; Pronzati G; Grasberger P; Probst CK; Black KE; Spinney JJ; Hariri LP; Nichols R; Lin Y; Bieler M; Seither P; Nicklin P; Wyatt D; Tager AM; Medoff BD
Am J Respir Cell Mol Biol; 2020 Apr; 62(4):479-492. PubMed ID: 31944822
[TBL] [Abstract][Full Text] [Related]
13. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins).
Eberlein M; Heusinger-Ribeiro J; Goppelt-Struebe M
Br J Pharmacol; 2001 Aug; 133(7):1172-80. PubMed ID: 11487529
[TBL] [Abstract][Full Text] [Related]
14. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy.
Danesh FR; Sadeghi MM; Amro N; Philips C; Zeng L; Lin S; Sahai A; Kanwar YS
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8301-5. PubMed ID: 12048257
[TBL] [Abstract][Full Text] [Related]
15. Effect of simvastatin, an inhibitor of hydroxy-methylglutaryl coenzyme A reductase, on the growth of human Ito cells.
Mallat A; Preaux AM; Blazejewski S; Dhumeaux D; Rosenbaum J; Mavier P
Hepatology; 1994 Dec; 20(6):1589-94. PubMed ID: 7982659
[TBL] [Abstract][Full Text] [Related]
16. Effects of different inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, pravastatin sodium and simvastatin, on sterol synthesis and immunological functions in human lymphocytes in vitro.
Kurakata S; Kada M; Shimada Y; Komai T; Nomoto K
Immunopharmacology; 1996 Aug; 34(1):51-61. PubMed ID: 8880225
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol inhibits the mevalonate pathway and potentiates the antiproliferative effects of simvastatin in rat theca-interstitial cells.
Wong DH; Villanueva JA; Cress AB; Sokalska A; Ortega I; Duleba AJ
Fertil Steril; 2011 Nov; 96(5):1252-8. PubMed ID: 21907337
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.
Laufs U; La Fata V; Plutzky J; Liao JK
Circulation; 1998 Mar; 97(12):1129-35. PubMed ID: 9537338
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells.
Wang ST; Ho HJ; Lin JT; Shieh JJ; Wu CY
Cell Death Dis; 2017 Feb; 8(2):e2626. PubMed ID: 28230855
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells.
Saito A; Saito N; Mol W; Furukawa H; Tsutsumida A; Oyama A; Sekido M; Sasaki S; Yamamoto Y
Melanoma Res; 2008 Apr; 18(2):85-94. PubMed ID: 18337644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
